Evidence map›Paper›PMID 41255654›Full record

ArticleJournal of clinical practice and research2025

Hepatitis B Serological Tests and Vitamin D Values: A Seasonal Assessment.

Adem Keskin, Mehmet Hakan Taskin, Mukadder Erdem, Mahir Igde, Ergin Kariptas, Recai Aci

Abstract read
In one paragraph

Article in Journal of clinical practice and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adem KeskinDepartment of Medicine Biochemistry, Institute of Health Sciences, Aydın Adnan Menderes University, Aydın, Türkiye.
Mehmet Hakan TaskinDepartment of Medical Microbiology, Samsun University Faculty of Medicine, Samsun, Türkiye.
Mukadder ErdemDepartment of Biochemistry, Samsun Training and Research Hospital, Samsun, Türkiye.
Mahir IgdeDepartment of Pediatric Allergy and Immunology, İstinye University Faculty of Medicine, İstanbul, Türkiye.
Ergin KariptasDepartment of Medical Microbiology, Samsun University Faculty of Medicine, Samsun, Türkiye.
Recai AciDepartment of Medical Services and Techniques, Aydın Adnan Menderes University, Söke Vocational School of Health Services, Aydın, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Hepatitis B virus (HBV), a significant global health concern, remains a source of infection despite the availability of effective vaccines. The progression of the disease is influenced by HBV antigens and autoimmune reactions. A deficiency in the immunomodulatory vitamin D is associated with the severity of various illnesses. The purpose of this research was to explore the relationship between HBV serological test results and 25-hydroxyvitamin D levels. Materials and Methods: The study included 120,004 HBV serological tests (Hepatitis B surface antigen (HBsAg), Hepatitis B e-antigen (HBeAg), anti-HBsAg, anti-HBeAg, antibodies to Hepatitis B core immunoglobulin G (anti-HBc IgG), and anti-HBc IgM) and 62.835 25-hydroxyvitamin D tests. Results: In spring, summer, and fall, 25-hydroxyvitamin D levels in HBsAg-positive individuals were lower compared to HBsAg-negative individuals. Conversely, 25-hydroxyvitamin D levels in individuals positive for anti-HBsAg were higher than those in anti-HBsAg-negative individuals across all seasons. Furthermore, in both cases of 25-hydroxyvitamin D deficiency and optimal 25-hydroxyvitamin D levels, individuals positive for anti-HBsAg showed higher 25-hydroxyvitamin D values than those negative for anti-HBsAg. Additionally, individuals positive for anti-HBc IgG demonstrated higher 25-hydroxyvitamin D levels compared to anti-HBc IgG-negative individuals during winter and fall. Moreover, 25-hydroxyvitamin D levels in individuals negative for anti-HbeAg were found to be below the optimal range. Conclusion: In conclusion, there may be a relationship between 25-hydroxyvitamin D levels and hepatitis B serological test positivity. Therefore, vitamin D levels should be monitored in populations affected by HBV.

Indexed as

Anti-hepatitis B surface antigenhepatitis B surface antigenhepatitis B virusserological testvitamin D deficiency

Identifiers

PMID41255654
PMCPMC12478786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.